Clinical trial
A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin…
NCT00131482 · Capstone Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00131482 |
|---|---|
| Title | A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist |
| Official title | A Double-blind, Randomized, Placebo-controlled Phase 2b Study to Establish the Effective Dose Range and to Evaluate the Safety of Chrysalin in Adult Subjects With a Fractured Distal Radius |
| Lead sponsor | Capstone Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Radius Fracture |
| Intervention type | Drug |
| Interventions | Chrysalin, Placebo |
| Enrollment | 274 |
| Start date | Nov 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Aug 18, 2005 |
| Last update posted | Aug 24, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: